CREATIVE BIOMOLECULES
Similar Organizations
Avantome
Avantome is a Biotechnology company.
Caliper Technologies
Caliper Technologies is a Biotechnology company.
Triton Biosciences
Triton Biosciences is a Biotechnology company.
Founder
More informations about "Creative Biomolecules"
Creative Biomolecules 2025 Company Profile: Valuation, Investors ...
Creative Biomolecules is headquartered in Hopkinton, MA. What is the size of Creative Biomolecules? Creative Biomolecules has 40 total employees. ... Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you โฆSee details»
Curis Emerges from Three Boston Biotech Companies
Feb 18, 2000 Creative BioMolecules focuses on therapies for human tissue regeneration based on morphogenic proteins, which are involved in the initiation and regulation of cellular events in the earliest stages of tissue and organ โฆSee details»
Creative Biomolecules - Crunchbase Company Profile & Funding
Organization. Creative Biomolecules . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Creative Biomolecules is a Biotechnology โฆSee details»
Creative Biomolecules - Products, Competitors, Financials, โฆ
Humanetics. Humanetics focuses on developing treatments for solid tumor cancers and inflammatory lung diseases. The company's lead candidate, BIO 300, is designed to enhance โฆSee details»
CREATIVE BIOMOLECULES, INC. :: Massachusetts (US)
May 10, 2000 Free and open company data on Massachusetts (US) company CREATIVE BIOMOLECULES, INC. (company number 942786743), 45 SOUTH ST., HOPKINTON, MA, โฆSee details»
Creative Biomolecules - 2025 Company Profile - Tracxn
Mar 9, 2025 Creative Biomolecules - Limited information available. Raised funding from 1 investor. Creative Biomolecules has 432 competitors.See details»
Creative Biomolecules Inc - Company Profile and News
Creative BioMolecules, Inc. develops products for the regeneration and restoration of human tissues and organs based on morphogenic proteins. The Company's OP-1 morphogenic โฆSee details»
Creative Biomolecules - Tech Stack, Apps, Patents & Trademarks
Creative Biomolecules is a Biotechnology company. Edit IT Spend by Aberdeen Section. This year,See details»
Creative Biomolecules, Inc. - VentureRadar
Creative Biomolecules, Inc. Follow Following Show more Show less. n/a Funding Signals. VENTURE FUNDED. Domain Associates. Export Similar Companies Similar Companies. โฆSee details»
Creative Biomolecules - Crunchbase
Creative Biomolecules is a Biotechnology company. Experience the new Crunchbase, powered by AI . Experience the new Crunchbase, powered by AISee details»
Creative Biomolecules, Inc. - Drug pipelines, Patents ... - Patsnap
ABSTRACT Bone morphogenetic protein (BMP)-6 is a member of the transforming growth factor (TGF)-ฮฒ superfamily, and is most similar to BMP-5, osteogenic protein (OP)-1/BMP-7, and OP โฆSee details»
Creative Biomolecules, Inc. - CA, DE, MA, and NH - Bizapedia
CREATIVE BIOMOLECULES, INC. NEW HAMPSHIRE FOREIGN PROFIT CORPORATION: WRITE REVIEW: Address: 45 South St Hopkinton, MA 01748: Registered Agent: The Prentice โฆSee details»
Three-way merger regenerates new company - Nature
The share price of Creative BioMoleculesโthe only one of the three that is publicly quotedโhad been about $5 for most of the past year, but nearly tripled in the days following the ...See details»
Creative BioMolecules Unveils Merger, Boosting Shares 30%
Creative BioMolecules Unveils Merger, Boosting Shares 30%. By a . Wall Street Journal. Staff Reporter. Share. Resize. HOPKINTON, Mass. -- In an unusual three-way merger of โฆSee details»
Creative BioMolecules Company Profile | Management and
Find contact information for Creative BioMolecules. Learn about their Business Services market share, competitors, and Creative BioMolecules's email format.See details»
COMPANY NEWS; CREATIVE BIOMOLECULES TO MERGE WITH โฆ
Feb 16, 2000 Creative BioMolecules Inc will merge with Ontogeny Inc and Reprogenesis Inc to form one of biggest companies working on stimulating human tissue growth to treat problems โฆSee details»
Curis - Pappas Capital
Curis (NASDAQ: CRIS) is the product of a three-way merger in 2000 of Pappas Capital portfolio company Reprogenesis with Creative Biomolecules and Ontogeny. The company was initially โฆSee details»
Creative Biomolecules, Inc. (Creative Biomolecules, Inc.) - ่ฏ็ฉ็ฎก โฆ
้กนไธ Creative Biomolecules, Inc. ็ธๅ ณ็ๆ็ฎ๏ผๅป่ฏ๏ผ 1999-10-15 · Journal of Cell Science 2ๅบ · ็็ฉๅญฆ Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast โฆSee details»
Creative Biomolecules - CB Insights
Humanetics. Humanetics focuses on developing treatments for solid tumor cancers and inflammatory lung diseases. The company's lead candidate, BIO 300, is designed to enhance โฆSee details»
CREATIVE BIOMOLECULES TO GO PUBLIC + | Bioworld | BioWorld
Mar 10, 1992 Creative Biomolecules Inc. said that it has filed for an initialpublic offering of 3.5 million shares of common stock priced at$10 to $12 per share. The Hopkinton, Mass., โฆSee details»